Doug E. Giordano has been Senior Vice President of Worldwide Business Development at Pfizer Inc. since June 2010. In this role, he is responsible for leading Pfizer’s evaluation, negotiation and execution of product licensing, partnerships and M&A transactions. Over the past nine years, Doug has led teams responsible for Pfizer acquisitions, product collaborations/licensing and Pfizer’s IPO/split out of Zoetis.
Before joining Pfizer’s Worldwide Business Development group in 2007, Doug held positions of increasing responsibility within Pfizer’s US Pharmaceuticals finance, manufacturing, commercial strategy and business development teams. He has been a key contributor to a variety of Pfizer transactions and a variety of innovative US commercialization initiatives including the creation and launch of the Pfizer/Microsoft/IBM collaboration, Amicore and the launch of the Pfizer for Living ShareCard, and Pfizer Helpful Answers programs.
Before his US pharmaceuticals operating role, Doug worked in a mergers and acquisitions capacity within Pfizer’s Medical Technology Group – playing a key part in Pfizer’s acquisitions, technology licensing and divestiture activity within Medtech.
Prior to joining Pfizer, Doug was a consultant at Booz, Allen & Hamilton (1987 – 1991).
Doug Giordano holds a Bachelor’s degree in biomedical engineering from Duke University (1984) and an M.B.A. degree from Cornell University’s Johnson School of Business (1991).